Tag Archives: OncoSec Medical

OncoSec Medical (ONCS) Initiated with a Buy at H.C. Wainwright

OncoSec Medical (NASDAQ: ONCS) received a Buy rating and a $4 price target from H.C. Wainwright analyst Ram Selvaraju today. The company’s shares closed yesterday at $1.51. Selvaraju observed: “Our price target is derived from a market value of $222M

H.C. Wainwright Keeps Their Buy Rating on OncoSec Medical

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on OncoSec Medical (NASDAQ: ONCS), with a price target of $4. The company’s shares closed yesterday at $1.34. Selvaraju noted: “We note that Ms. O’Connor, know

OncoSec Medical Receives a Buy from H.C. Wainwright

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on OncoSec Medical (NASDAQ: ONCS) today and set a price target of $4. The company’s shares closed yesterday at $1.47. Selvaraju observed: “We have adjusted our projections and we currently estimate

H.C. Wainwright Reaffirms Their Buy Rating on OncoSec Medical

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on OncoSec Medical (NASDAQ: ONCS), with a price target of $4. The company’s shares closed on Friday at $1.57. According to TipRanks.com, Selvaraju is ranked 0

Maxim Group Reaffirms Their Buy Rating on OncoSec Medical

In a report released today, Jason McCarthy from Maxim Group maintained a Buy rating on OncoSec Medical (NASDAQ: ONCS), with a price target of $5. The company’s shares opened today at $1.80. McCarthy wrote: “OncoSec provided an update on TAVO

Maxim Group Assigns a Buy Rating on OncoSec Medical

In a report released today, Jason McCarthy from Maxim Group assigned a Buy rating to OncoSec Medical (NASDAQ: ONCS), with a price target of $5. The company’s shares opened today at $1.97. McCarthy commented: “Oncosec announced positive data from a